Comparison of common side effects from mood stabilizers and antipsychotics between pediatric and adult patients with bipolar disorder: a systematic review of randomized, double-blind, placebo-controlled trials
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2019.1632832
Abstract: ABSTRACT Introduction: To compare common side effects of mood stabilizers (MSs) and antipsychotics in pediatric and adult bipolar disorder (BD). Area covered: MEDLINE, EMBASE, PsycINFO was searched for randomized, double-blind, placebo-controlled trials (RCTs) in the… read more here.
Keywords: common side; side effects; adult; pediatric adult ... See more keywords
Dyspnea: Common Side Effect.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical journal of oncology nursing"
DOI: 10.1188/21.cjon.s2.10-12
Abstract: For dyspnea, standards of care are based on emerging evidence-based practice. Dyspnea, or shortness of breath, is a subjective experience of breathing discomfort marked by distinct sensations of varying intensity. Resulting from interactions among physiologic, psychological,… read more here.
Keywords: common side; dyspnea; side effect; dyspnea common ... See more keywords
Germline Hereditary Risk: Common Side Effects.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical journal of oncology nursing"
DOI: 10.1188/21.cjon.s2.21-22
Abstract: For germline (hereditary) risk, standards of care are based on emerging evidence-based practice. Cancer may affect any individual, but some people are at higher risk than others. The majority of cancer cases are sporadic, caused by… read more here.
Keywords: risk common; common side; germline hereditary; cancer ... See more keywords
Case Report: Alpelisib-Induced Drug Reaction With Eosinophilia and Systemic Symptoms: A Rare Manifestation of a Common Side Effect
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.726785
Abstract: Alpelisib is a PIK3a inhibitor approved for the treatment of metastatic ER+ breast cancer in combination with fulvestrant. Although rash is a common side effect of this medication, we present the first case of drug… read more here.
Keywords: common side; case; alpelisib; reaction eosinophilia ... See more keywords